Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

5 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Dec. 12, 2019 NERV S 3,113 $7.42 $23,098 33,770 Direct -8.44% Disposed -94.5% (price as of 2026-10-02)
Dec. 12, 2018 NERV S 3,117 $7.96 $24,811 36,883 Direct -7.79% Disposed -94.8% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
June 19, 2020 NERV Employee Stock Option (right to buy) Common Stock (185,025) $7.11 Dec. 31, 2029 185,025 Acquired
Dec. 31, 2019 NERV Employee Stock Option (right to buy) Common Stock (49,975) $7.11 Dec. 30, 2029 49,975 Acquired
Dec. 11, 2018 NERV Employee Stock Option (right to buy) Common Stock (260,000) $7.96 Dec. 10, 2028 260,000 Acquired
Dec. 11, 2017 NERV Employee Stock option (Right to Buy) Common Stock (775,000) $6.05 Dec. 10, 2027 775,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).